Lexicon Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Lexicon Pharmaceuticals Inc Stock! Lexicon Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Lexicon Pharmaceuticals Inc Stock!


Lexicon Pharmaceuticals, Inc. engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. The company is headquartered in The Woodlands, Texas and currently employs 135 full-time employees. The company went IPO on 2000-04-07. The firm is focused on the discovery, development, and commercialization of pharmaceutical products for the treatment of human disease. Its pipeline includes Sotagliflozin, LX9211, and LX2761. Sotagliflozin is an orally-delivered small molecule compound that is being developed for the treatment of heart failure and type I diabetes, and type II diabetes mellitus, chronic kidney disease and other cardiovascular risk factors. LX9211 is an orally-delivered small molecule compound that is being developed for the treatment of neuropathic pain. The firm is conducting a Phase II clinical trial of LX9211 in diabetic peripheral neuropathic pain and a second Phase II clinical trial of LX9211 in post-herpetic neuralgia. Its LX2761 is an orally-delivered small molecule compound that is designed to inhibit sodium-glucose cotransporter 1 (SGLT1) locally in the gastrointestinal tract without any inhibition of SGLT2 in the kidney.



Lexicon Pharmaceuticals Inc Stock Price. Everything You Need To Know About The Lexicon Pharmaceuticals Inc Stock! performance

  • Employees 135
  • Company HQ The Woodlands
  • Website https://www.lexpharma.com/
  • LXRX Asset Type Common Stock
  • LXRX Market Capitalization 686.8M
  • Earnings Per Share -0.83
  • Dividends Per Share None
  • Dividend Date None
  • Quarterly Earnings Growth -0.634

Are you a retail investor from Malaysia, Thailand, Indonesia or Vietnam looking to expand your investment portfolio? Consider investing in Lexicon Pharmaceuticals, a leading biopharmaceutical company specializing in the discovery and development of innovative treatments for various diseases. With a diverse pipeline of potential therapies, Lexicon has a strong track record of success and a promising future. But how can you invest in Lexicon Pharmaceuticals from your home country? Zorion, the investment platform designed specifically for retail investors in Malaysia, Thailand, Indonesia and Vietnam, offers easy access to real US stocks like Lexicon Pharmaceuticals. With investment insights, recommendations, and educational resources at your disposal, Zorion empowers you to make informed investment decisions. Start investing in Lexicon Pharmaceuticals today and maximize your potential for profitable returns.


Want To Buy Lexicon Pharmaceuticals Inc Stock From Malaysia, Indonesia, Thailand or Philippines? You may also be interested in: